We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$12.8B
AUM Growth
+$1.36B
Cap. Flow
+$773M
Cap. Flow %
6.06%
Top 10 Hldgs %
12.57%
Holding
2,812
New
294
Increased
855
Reduced
703
Closed
290

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$28.3M
2
HAL icon
Halliburton
HAL
+$24.2M
3
EA icon
Electronic Arts
EA
+$23.9M
4
ICON
Iconix Brand Group, Inc.
ICON
+$23.7M
5
HELE icon
Helen of Troy
HELE
+$20.4M

Sector Composition

Rank Sector Weight
1 Technology 14.92%
2 Healthcare 14.07%
3 Industrials 12.64%
4 Financials 10.64%
5 Consumer Discretionary 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFIV icon
276
F5
FFIV
$22.1B
$14.2M 0.11%
109,196
+67,366
+161% +$8.4M
CAM
277
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
$14M 0.11%
280,076
+101,879
+57% +$5.64M
PL
278
DELISTED
PROTECTIVE LIFE CORP
PL
$13.9M 0.11%
199,753
+183,266
+1,112% +$12.8M
JCI icon
279
Johnson Controls International
JCI
$87.5B
$13.8M 0.11%
273,273
+523
+0.2% +$25.6K
MCK icon
280
McKesson
MCK
$98.5B
$13.8M 0.11%
66,574
-833
-1% -$169K
AFSI
281
DELISTED
AmTrust Financial Services, Inc.
AFSI
$13.8M 0.11%
490,794
-617,260
-56% -$15.5M
TCF
282
DELISTED
TCF Financial Corporation Common Stock
TCF
$13.7M 0.11%
446,629
+30,287
+7% +$873K
LUMN icon
283
Lumen
LUMN
$6.53B
$13.7M 0.11%
345,050
+334,585
+3,197% +$13.4M
NVO
284
Novo Nordisk
NVO
$216B
$13.6M 0.11%
642,956
-19,982
-3% -$446K
MTZ icon
285
MasTec
MTZ
$26.7B
$13.3M 0.1%
586,941
-259,001
-31% -$6.41M
EFAV icon
286
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.22B
$13.2M 0.1%
+214,746
New +$13.4M
AMAG
287
DELISTED
AMAG Pharmaceuticals
AMAG
$13.2M 0.1%
+310,895
New +$11.2M
AGN
288
DELISTED
Allergan plc
AGN
$13.2M 0.1%
51,469
+3,448
+7% +$862K
WDC icon
289
Western Digital
WDC
$179B
$13.2M 0.1%
157,227
-8,635
-5% -$652K
DTV
290
DELISTED
DIRECTV COM STK (DE)
DTV
$13.1M 0.1%
151,644
-315
-0.2% -$27.1K
VAR
291
DELISTED
Varian Medical Systems, Inc.
VAR
$13.1M 0.1%
172,979
-8,332
-5% -$620K
SNDK
292
DELISTED
SANDISK CORP
SNDK
$13M 0.1%
132,227
-5,270
-4% -$504K
RPXC
293
DELISTED
RPX Corporation
RPXC
$12.9M 0.1%
935,663
+54,546
+6% +$756K
JWN
294
DELISTED
Nordstrom
JWN
$12.9M 0.1%
162,214
-8,198
-5% -$602K
SNI
295
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$12.9M 0.1%
170,911
+2,722
+2% +$208K
BRCD
296
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$12.9M 0.1%
1,085,896
+339,431
+45% +$3.68M
MPC icon
297
Marathon Petroleum
MPC
$90.3B
$12.8M 0.1%
283,468
-31,234
-10% -$1.37M
PRE
298
DELISTED
PARTNERRE LTD
PRE
$12.8M 0.1%
112,068
+21,668
+24% +$2.47M
PSX icon
299
Phillips 66
PSX
$82.9B
$12.7M 0.1%
177,248
+25,101
+16% +$1.85M
BRK.A icon
300
Berkshire Hathaway Class A
BRK.A
$1.07T
$12.7M 0.1%
56
+2
+4% +$433K

Similar funds

Glenmede Trust's Q4 2014 Portfolio in Review

As of Q4 2014, Glenmede Trust held 2,812 positions worth $12.8B, up 12% from $11.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust deployed $773M of net new capital in Q4 2014, opening 294 new positions and adding to 855 existing holdings. Its largest new stake was Portland General Electric: 447,386 shares worth $16.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was eBay, an estimated $18.8M trimmed.

  • Glenmede Trust's largest Q4 2014 buy was Portland General Electric: 447,386 shares worth $16.9M.
  • Glenmede Trust added most to Labcorp in Q4 2014, an estimated $28.3M increase.
  • Glenmede Trust's biggest Q4 2014 reduction was eBay, cutting an estimated $18.8M.
  • Glenmede Trust fully exited SAPIENT CORP in Q4 2014, selling an estimated $16.9M.
  • Glenmede Trust's ten largest holdings make up 13% of its $12.8B portfolio in Q4 2014.
  • Glenmede Trust opened 294 new positions and closed 290 in Q4 2014.
  • Glenmede Trust's portfolio value rose 12% quarter-over-quarter to $12.8B.

Based on Glenmede Trust's 13F filing for Q4 2014, filed 6 Feb 2015.